Issue 12, 2011

The anti-tumor antibioticPD 113,271 binds to microtubule-associated protein 1B (MAP1B)

Abstract

PD 113,271 and fostriecin are structurally related phosphate monoesters with potent cytotoxicity against several tumor cell lines. Although there have been several biological studies on fostriecin such as that on protein phosphatase (PP) 2A inhibition and its mode of action, little is known about PD 113,271. In the present study, we identified microtubule-associated protein (MAP) 1B as a binding protein of PD 113,271 using phage display biopanning. Phages that expressed the highly basic region of MAP1B bound to the immobilized PD 113,271. In addition, PD 113,271 bound to MAP1B in the lysate of human liver cells. Moreover, we identified that PD 113,271 directly interfered with MAP1B binding to microtubules and induced a morphological abnormality in the distribution of MAP1B in cells. These results showed that PD 113,271 binds to the tubulin binding domain of MAP1B and may be useful for studying MAP1B function.

Graphical abstract: The anti-tumor antibiotic PD 113,271 binds to microtubule-associated protein 1B (MAP1B)

Article information

Article type
Concise Article
Submitted
22 Mar 2011
Accepted
23 May 2011
First published
14 Sep 2011

Med. Chem. Commun., 2011,2, 1174-1180

The anti-tumor antibiotic PD 113,271 binds to microtubule-associated protein 1B (MAP1B)

T. Takeuchi, T. Imai, K. Ishi, T. Saitoh, K. Kuramochi and F. Sugawara, Med. Chem. Commun., 2011, 2, 1174 DOI: 10.1039/C1MD00080B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements